-
1
-
-
0036657493
-
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
-
Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002 47 : 1 17.
-
(2002)
J Am Acad Dermatol
, vol.47
, pp. 1-17
-
-
Berg, D.1
Otley, C.C.2
-
3
-
-
0037341914
-
Defining the clinical course of metastatic skin cancer in organ transplant recipients: A multicenter collaborative study
-
Martinez JC, Otley CC, Stasko T et al. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003 139 : 301 6.
-
(2003)
Arch Dermatol
, vol.139
, pp. 301-6
-
-
Martinez, J.C.1
Otley, C.C.2
Stasko, T.3
-
4
-
-
0033560767
-
Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience
-
Veness MJ, Quinn DI, Ong CS et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999 85 : 1758 64.
-
(1999)
Cancer
, vol.85
, pp. 1758-64
-
-
Veness, M.J.1
Quinn, D.I.2
Ong, C.S.3
-
5
-
-
0027515923
-
De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation
-
Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993 25 : 1383 4.
-
(1993)
Transplant Proc
, vol.25
, pp. 1383-4
-
-
Sheil, A.G.1
Disney, A.P.2
Mathew, T.H.3
Amiss, N.4
-
6
-
-
0032973963
-
Skin cancer in Australian heart transplant recipients
-
Ong CS, Keogh AM, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999 40 : 27 34.
-
(1999)
J Am Acad Dermatol
, vol.40
, pp. 27-34
-
-
Ong, C.S.1
Keogh, A.M.2
Kossard, S.3
-
7
-
-
0029097249
-
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: A double-blind, placebo-controlled study
-
Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995 13 : 1933 8.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1933-8
-
-
Bavinck, J.N.1
Tieben, L.M.2
Van Der Woude, F.J.3
-
8
-
-
15044345553
-
Reduction of immunosuppression for transplant-associated skin cancer: Rationale and evidence of efficacy
-
Otley CC, Maragh SL. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005 31 : 163 8.
-
(2005)
Dermatol Surg
, vol.31
, pp. 163-8
-
-
Otley, C.C.1
Maragh, S.L.2
-
9
-
-
0036097712
-
Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression
-
Duman S, Toz H, Asci G et al. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Transplant 2002 17 : 892 6.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 892-6
-
-
Duman, S.1
Toz, H.2
Asci, G.3
-
10
-
-
0035025775
-
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients
-
Tsai DE, Hardy CL, Tomaszewski JE et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 2001 71 : 1076 88.
-
(2001)
Transplantation
, vol.71
, pp. 1076-88
-
-
Tsai, D.E.1
Hardy, C.L.2
Tomaszewski, J.E.3
-
11
-
-
0035678741
-
Controlling the incidence of infection and malignancy by modifying immunosuppression
-
Soulillou JP, Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001 72 (Suppl. 12 S89 93.
-
(2001)
Transplantation
, vol.72
, Issue.12
-
-
Soulillou, J.P.1
Giral, M.2
-
12
-
-
0032574187
-
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens
-
Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998 351 : 623 8.
-
(1998)
Lancet
, vol.351
, pp. 623-8
-
-
Dantal, J.1
Hourmant, M.2
Cantarovich, D.3
-
13
-
-
0035051159
-
Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants
-
Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001 137 : 459 63.
-
(2001)
Arch Dermatol
, vol.137
, pp. 459-63
-
-
Otley, C.C.1
Coldiron, B.M.2
Stasko, T.3
Goldman, G.D.4
-
14
-
-
1942508212
-
Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma
-
Moloney FJ, Kelly PO, Kay EW et al. Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma. Dermatol Surg 2004 30 : 674 8.
-
(2004)
Dermatol Surg
, vol.30
, pp. 674-8
-
-
Moloney, F.J.1
Kelly, P.O.2
Kay, E.W.3
-
15
-
-
0033007170
-
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
-
Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999 40 : 177 86.
-
(1999)
J Am Acad Dermatol
, vol.40
, pp. 177-86
-
-
Jensen, P.1
Hansen, S.2
Moller, B.3
-
16
-
-
0343852703
-
Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients
-
Glover MT, Deeks JJ, Raftery MJ et al. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet 1997 349 : 398.
-
(1997)
Lancet
, vol.349
, pp. 398
-
-
Glover, M.T.1
Deeks, J.J.2
Raftery, M.J.3
-
17
-
-
0028244603
-
Triple therapy and incidence of de novo cancer in renal transplant recipients
-
Kehinde EO, Petermann A, Morgan JD et al. Triple therapy and incidence of de novo cancer in renal transplant recipients. Br J Surg 1994 81 : 985 6.
-
(1994)
Br J Surg
, vol.81
, pp. 985-6
-
-
Kehinde, E.O.1
Petermann, A.2
Morgan, J.D.3
-
18
-
-
0024521962
-
Epidermal dysplasia and cyclosporine therapy in renal transplant patients: A comparison with azathioprine
-
Shuttleworth D, Marks R, Griffin PJ, Salaman JR. Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine. Br J Dermatol 1989 120 : 551 4.
-
(1989)
Br J Dermatol
, vol.120
, pp. 551-4
-
-
Shuttleworth, D.1
Marks, R.2
Griffin, P.J.3
Salaman, J.R.4
-
19
-
-
0030962571
-
Malignancy after renal transplantation: Analysis of incidence and risk factors in 1 700 patients followed during a 25-year period
-
Hiesse C, Rieu P, Kriaa F et al. Malignancy after renal transplantation: analysis of incidence and risk factors in 1 700 patients followed during a 25-year period. Transplant Proc 1997 29 : 831 3.
-
(1997)
Transplant Proc
, vol.29
, pp. 831-3
-
-
Hiesse, C.1
Rieu, P.2
Kriaa, F.3
-
20
-
-
0034235161
-
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients
-
Ramsay HM, Fryer AA, Reece S et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000 36 : 167 76.
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 167-76
-
-
Ramsay, H.M.1
Fryer, A.A.2
Reece, S.3
-
21
-
-
0033999806
-
Skin cancer in heart transplant recipients: Frequency and risk factor analysis
-
Fortina AB, Caforio AL, Piaserico S et al. Skin cancer in heart transplant recipients: frequency and risk factor analysis. J Heart Lung Transplant 2000 19 : 249 55.
-
(2000)
J Heart Lung Transplant
, vol.19
, pp. 249-55
-
-
Fortina, A.B.1
Caforio, A.L.2
Piaserico, S.3
-
22
-
-
0000716939
-
Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
-
Gjersvik P, Hansen S, Moller B et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 2000 13 (Suppl. 1 S380 1.
-
(2000)
Transpl Int
, vol.13
, Issue.1
-
-
Gjersvik, P.1
Hansen, S.2
Moller, B.3
-
23
-
-
21644437017
-
Strategies for minimizing immunosuppression in kidney transplantation
-
Kirk AD, Mannon RB, Swanson SJ, Hale DA. Strategies for minimizing immunosuppression in kidney transplantation. Transpl Int 2005 18 : 2 14.
-
(2005)
Transpl Int
, vol.18
, pp. 2-14
-
-
Kirk, A.D.1
Mannon, R.B.2
Swanson, S.J.3
Hale, D.A.4
-
24
-
-
33644899100
-
Reduction of Immunosuppression Task Force of the International Transplant Skin Cancer Collaborative and the Skin Care in Organ Transplant Patients Europe. Reduction of immunosuppression for transplant-associated skin cancer: Expert consensus survey
-
Otley CC, Berg D, Ulrich C et al. Reduction of Immunosuppression Task Force of the International Transplant Skin Cancer Collaborative and The Skin Care in Organ Transplant Patients Europe. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol 2006 154 : 395 400.
-
(2006)
Br J Dermatol
, vol.154
, pp. 395-400
-
-
Otley, C.C.1
Berg, D.2
Ulrich, C.3
-
25
-
-
0035880957
-
Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
-
Balch CM, Soong SJ, Gershenwald JE et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001 19 : 3622 34.
-
(2001)
J Clin Oncol
, vol.19
, pp. 3622-34
-
-
Balch, C.M.1
Soong, S.J.2
Gershenwald, J.E.3
-
26
-
-
0030040747
-
Malignant melanoma in organ allograft recipients
-
Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996 61 : 274 8.
-
(1996)
Transplantation
, vol.61
, pp. 274-8
-
-
Penn, I.1
-
27
-
-
0026773479
-
Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection
-
Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992 26 : 976 90.
-
(1992)
J Am Acad Dermatol
, vol.26
, pp. 976-90
-
-
Rowe, D.E.1
Carroll, R.J.2
Day Jr., C.L.3
-
28
-
-
0033853911
-
Post-transplant malignancy: The role of immunosuppression
-
Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf 2000 23 : 101 13.
-
(2000)
Drug Saf
, vol.23
, pp. 101-13
-
-
Penn, I.1
-
30
-
-
10744227990
-
Ten years of sirolimus therapy for human renal transplantation: The University of Texas at Houston experience
-
Kahan BD, Knight R, Schoenberg L et al. Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience. Transplant Proc 2003 35 (Suppl. 25S 34S.
-
(2003)
Transplant Proc
, vol.35
-
-
Kahan, B.D.1
Knight, R.2
Schoenberg, L.3
-
31
-
-
4043142865
-
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: Results from five multicenter studies
-
Mathew T, Kries H, Friend P. Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004 18 : 446 9.
-
(2004)
Clin Transplant
, vol.18
, pp. 446-9
-
-
Mathew, T.1
Kries, H.2
Friend, P.3
-
32
-
-
27644436740
-
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
-
Kauffman HM, Cherikh WS, Cheng Y et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005 80 : 883 9.
-
(2005)
Transplantation
, vol.80
, pp. 883-9
-
-
Kauffman, H.M.1
Cherikh, W.S.2
Cheng, Y.3
|